The RADIANCE-HTN SOLO trial, published in The Lancet in May 2018, marks a significant stride in hypertension treatment research. This trial focused on the safety and efficacy of a novel endovascular ultrasound renal denervation procedure compared to a sham procedure … Read More
Blog
NOAH-AFNET 6 Trial: Edoxaban in AHRE
The NOAH-AFNET 6 trial, as outlined in a groundbreaking study from the New England Journal of Medicine in 2023, represents a significant advancement in our understanding of atrial fibrillation management. This study scrutinized the efficacy of edoxaban, a novel oral … Read More
SELECT Trial: Semaglutide and CV outcomes
Semaglutide Improve CV events? SELECT Trial Summary The SELECT trial, a pivotal study published in the New England Journal of Medicine (NEJM) in November 2023, has offered the medical community valuable insights into the treatment of cardiovascular (CV) events in … Read More
DUPLEX Trial: Sparsentan in FSGS
The DUPLEX Trial: Evaluating Kidney Protection in FSGS Patients The DUPLEX trial, a rigorous study published in the New England Journal of Medicine in 2023, has garnered significant attention in the nephrology community. The trial investigated the long-term nephroprotective potential … Read More
ORBITA-2 Trial: PCI in Stable Angina
Understanding the Impact of PCI in Stable Angina: Insights from the ORBITA-2 Trial The ORBITA-2 trial has emerged as a cornerstone study in the field of cardiology, particularly in the treatment of stable angina through Percutaneous Coronary Intervention (PCI). This … Read More
ACT HIV Trial: Dexamethasone in TB Meningitis
ACT HIV TRIAL (2023) Summary and Key Points In 2023, a significant study titled the “ACT HIV TRIAL” was published, which delved into the potential benefits of using adjunctive dexamethasone for the treatment of tuberculous meningitis in HIV-positive adults. This … Read More
ASAP Trial: Vancomycin and Cefazolin in Arthroplasty Prophylaxis
The ASAP Trial: Vancomycin and Cefazolin in Arthroplasty Prophylaxis – An Analysis The realm of surgical prophylaxis has always been a topic of deep medical interest, aiming to prevent complications and ensure the best outcomes for patients. One such endeavor … Read More
NSCLC Treatment: The AEGEAN Trial Breakthrough
“Innovations in NSCLC Treatment: The AEGEAN Trial Breakthrough” In recent years, the pursuit of more effective treatments for non-small-cell lung cancer (NSCLC) has been relentless. The AEGEAN trial of 2023, as reported in the esteemed New England Journal of Medicine … Read More
T-PASS Trial: A Shift in Post-Stenting Treatment for ACS
T-PASS Trial Summary The management of Acute Coronary Syndrome (ACS) after stenting has been a hot topic for medical researchers for years. The recent T-PASS Trial in 2023 has shed light on the possible advantages of shifting from the conventional … Read More
AMIKINHAL Trial: Inhaled Amikacin in Preventing VAP
The medical world is continually seeking innovative methods to combat and prevent life-threatening conditions. One such condition is ventilator-associated pneumonia, a severe complication that affects patients undergoing mechanical ventilation. The recent AMIKINHAL trial, a multicenter, double-blind, randomized, controlled, superiority study, … Read More